Evidence map›Paper›PMID 35859269›Full record

ArticlePediatric dermatology2022

Successful treatment of a child's pityriasis rubra pilaris (PRP) with ustekinumab and acitretin.

Medek Katharina, Selhofer Sylvia, Buchner Matthias, Mrowietz Ulrich, Laimer Martin

Erratum issuedOpen access · hybridAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Pediatric dermatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Tofacitinib for Pityriasis Rubra Pilaris: A Case Report.Clinical, cosmetic and investigational dermatology · 2024
    Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Medek KatharinaDepartment of Dermatology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria.ORCID https://orcid.org/0000-0001-7019-4734
Selhofer SylviaDepartment of Dermatology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria.
Buchner MatthiasDepartment of Pediatrics, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria.
Mrowietz UlrichPsoriasis-Center at the Department of Dermatology, University Medical Center Schleswig-Holstein, Kiel, Germany.
Laimer MartinDepartment of Dermatology, University Hospital of the Paracelsus Medical University Salzburg, Salzburg, Austria.
Paracelsus Medical University · ATUniversity Hospital Schleswig-Holstein · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pityriasis rubra pilaris (PRP) is a rare inflammatory skin disease that occurs with phenotypic variability in adults of all ages as well as in children. Data on the treatment of PRP is limited. Here, we report a 5-year-old girl with widespread skin involvement and prominent palmoplantar hyperkeratosis who was initially treated for psoriasis. After reevaluation, a diagnosis of PRP was made, and the patient had an excellent therapeutic response to ustekinumab and acitretin.

Indexed as

Pityriasis Rubra PilarisPsoriasisAcitretinAdultChildChild, PreschoolFemaleHumansUstekinumabAcitretinUstekinumabchildrenpityriasis rubra pilarisretinoidssuccessful treatmentustekinumab

Identifiers

PMID35859269
PMCPMC9541132
OpenAlexW4286472133

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.